How Rich Countries Are 'Hoarding' The World's Vaccines, In Charts
Experts say low-risk people in the U.S. will likely be immunized before many high-risk people in poor countries.
moderna
Moderna's Vaccine Trial Sites, Including Wake Forest Baptist, Continue Study
Data on the effectiveness of the Moderna vaccine looks promising, but the trial will continue for months to come. Some of that research is happening at Wake Forest Baptist Health in Winston-Salem.
Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?
One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.
Moderna's COVID-19 Vaccine Shines In Clinical Trial
The vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30,000 people.
How Can You Tell If A COVID-19 Vaccine Is Working?
Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?
'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
HHS To Help Companies Develop COVID-19 Vaccines
The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.